Position in SNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,165,322
-$3,770,164 QoQ
Shares Held
97,640
-40.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#129
of 712 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GQG Partners LLC holds $855,412,874 across 8 Drug Manufacturers - General names. SNY ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,921,614 | $483,554,946 | |
| 2 | NVS |
Novartis AG
|
2,151,131 | $337,125,250 | |
| 3 | AZN |
Astrazeneca PLC
|
45,569 | $8,640,793 | |
| 4 | MRK |
Merck & Co., Inc.
|
53,092 | $6,822,322 | |
| 5 | JNJ |
Johnson & Johnson
|
25,158 | $6,389,377 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
96,264 | $5,546,731 | |
| 7 | SNY |
Sanofi
This page
|
97,640 | $4,165,322 | |
| 8 | PFE |
Pfizer Inc
|
131,567 | $3,168,133 |
All Filings in SNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,165,322 | 97,640 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $7,935,486 | 164,705 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,861,043 | 120,946 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,047,400 | 85,750 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $202,262 | 3,647 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||